Innate Pharma SA Noncurrent Liabilities
Innate Pharma SA (IPHYF) had Noncurrent Liabilities of EUR 47.77 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:NoncurrentLiabilities · last filed 2026-04-01
- 2025-12-31: Noncurrent Liabilities 47.77M EUR.
- 2025-06-30: Noncurrent Liabilities 58.37M EUR.
- 2024-12-31: Noncurrent Liabilities 69.24M EUR.
- 2024-06-30: Noncurrent Liabilities 84.48M EUR.
| Period end | Noncurrent Liabilities | Noncurrent Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 47.77M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 58.37M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 69.24M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 84.48M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 83.65M EUR 20-F · filed 2026-04-01 | 92.66M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 103.52M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 103.81M EUR 20-F · filed 2025-04-30 | 112.37M EUR 20-F · filed 2023-04-06 |
| 2022-06-30 | 90.54M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 80.17M EUR 20-F · filed 2024-04-04 | 80.17M EUR 20-F · filed 2022-04-04 |
| 2021-06-30 | 90.04M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 105.96M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 62.12M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 87.24M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 95.16M EUR 20-F · filed 2020-04-24 |